Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583359 · ClinicalTrials.gov registry record · NA
Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT03583359 is a NA study that has completed, run by Merz North America. The registered enrollment target is 180 participants.
The verdict
NCT03583359, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
To demonstrate the effectiveness and safety of Radiesse (+) following deep (subdermal and/or supraperiosteal) injection to improve the contour of jawline by adding volume to the jawline.
Interventions
- DEVICE Radiesse (+)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-08-06 |
| Est. Completion | 2020-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03583359
The ClinicalTrials.gov registry entry for NCT03583359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiesse (+) is the first listed.
NCT03583359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03583359 about?
NCT03583359 is a clinical study titled "Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline". To demonstrate the effectiveness and safety of Radiesse (+) following deep (subdermal and/or supraperiosteal) injection to improve the contour of jawline by adding volume to the jawline.
What is the current status of trial NCT03583359?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2018-08-06. Estimated completion is 2020-03-27.
What interventions are being tested in trial NCT03583359?
The interventions under investigation include: Radiesse (+) (DEVICE).
Who is sponsoring clinical trial NCT03583359?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.